|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Depreciation and amortization | |||||
| Amortization and accretion of loans and other assets | |||||
| Amortization and accretion on investment securities | |||||
| Deferred income taxes | |||||
| Equity security (gains) losses, net | |||||
| Available for sale security (gains) losses, net | |||||
| Earnings on bank owned life insurance | |||||
| Stock awards | |||||
| Originations of loans held for sale | |||||
| Proceeds from sales of loans held for sale | |||||
| Realized gains on loans sold | |||||
| Realized gains on sale of Braavo | |||||
| (Increase) decrease in accrued interest receivable | |||||
| Increase (decrease) in accrued interest payable | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Proceeds from sales of available-for-sale securities | |||||
| Proceeds from maturity and principal repayments of securities | |||||
| Purchase of securities | |||||
| Purchase of equity securities | |||||
| Proceeds from sale of equity securities | |||||
| Proceeds from redemption of Regulatory Stock | |||||
| Purchase of Regulatory Stock | |||||
| Net increase in loans | |||||
| Purchase of interest bearing time deposits | |||||
| Proceeds from matured interest bearing time deposits with other banks | |||||
| Proceeds from sale of interest bearing time deposits with other banks | |||||
| Purchase of bank owned life insurance | |||||
| Purchase of premises, equipment and software | |||||
| Proceeds from sale of premises and equipment | |||||
| Proceeds from bank owned life insurance | |||||
| Investments in low income housing partnerships | |||||
| Proceeds from sale of foreclosed assets held for sale | |||||
| Proceeds from sale of Braavo assets | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Net (decrease) increase in deposits | |||||
| Proceeds from long-term borrowings | |||||
| Repayments of long-term borrowings | |||||
| Net increase (decrease) in short-term borrowed funds | |||||
| Purchase of treasury stock | |||||
| Purchase of restricted stock | |||||
| Sale of treasury stock | |||||
| Issuance of common stock for employee stock purchase plan | |||||
| Dividends paid | |||||
| Net cash (used in) provided by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and Cash Equivalents at Beginning of Year | |||||
| Cash and Cash Equivalents at End of Year | |||||
| Supplemental Disclosures of Cash Flow Information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Non-cash activities: | |||||
| Stock dividend | |||||
| Real estate acquired in settlement of loans | |||||
| Investments matured and not settled included in other assets | |||||
| Investments in low income housing included in other assets and liabilities | |||||
| Right of use asset and liability | |||||
| CECL adjustment | |||||
| Non-cash assets acquired | |||||
| Available-for-sale securities | |||||
| Interest bearing time deposits with other banks | |||||
| Loans held fo sale | |||||
| Loans | |||||
| Premises and equipment | |||||
| Accrued interest receivable | |||||
| Bank owned life insurance | |||||
| Intangibles | |||||
| Deferred tas asset | |||||
| Other assets | |||||
| Goodwill | |||||
| HV Bancorp, Inc. | |||||
| Total goodwill | |||||
| Total non-cash assets acquired | |||||
| Liabilities assumed | |||||
| Noninterest-bearing deposits | |||||
| Interest-bearing deposits | |||||
| Accrued interest payable | |||||
| Borrowed funds | |||||
| Other liabilities | |||||
| Total liabilities assumed | |||||
| Net non-cash assets acquired | |||||
| Cash and cash equivalents acquired | |||||
Loading...